Stock Analysis of Abeona Therapeutics Inc (ABEO) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code ABEO
Close 4.40
Change -0.200 / 4.35 %
Volume 522862
Vol Change 21790.00 / 4.35 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthNeutral
Growth Index Very Low Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index Very Low Stability Stock


Fundamental View of Abeona Therapeutics Inc
PE (TTM)

-392.99

Very Poor
Price / Book

2686.57

Very Poor
Price / Sales

4763.77

Very Poor
Piotroski F Score

2.0

Poor
Market Cap

179734 K

Enterprise Value

165921 K

ROA (TTM)

-122.93

Very Poor
ROE (TTM)

-683.63

Very Poor
Net Margin (TTM)

-1212.19

Very Poor
Revenue

152.33 %

3568.00 K
Net Profit

2.85 %

-44718.00 K
Debt to Equity

0.067

Excellent
Altman Z Score

-15.62

Very Poor
Quick Ratio

0

Poor
Cash Ratio

3.92

Very Good


Highs/Lows of Abeona Therapeutics Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week4.2 4.76 % 1.54 % 4.944.0915-May-2414-May-24
Two Week4.6 4.35 % 3.42 % 5.0654.0907-May-2414-May-24
One Month7.93 44.51 % 5.60 % 8.173.0518-Apr-2425-Apr-24
Three Month7.01 37.23 % 5.95 % 9.013.0506-Mar-2425-Apr-24
Six Months4.19 5.01 % 17.48 % 9.013.0506-Mar-2425-Apr-24
One year2.96 48.65 % 27.52 % 9.012.8506-Mar-2408-Aug-23
Two year4.3725 0.629 % 29.70 % 9.012.1906-Mar-2424-Feb-23
Five year186.0 97.63 % 85.46 % 9.012.1906-Mar-2424-Feb-23
Ten year552.5 99.20 % 182.41 % 587.52.1922-May-1424-Feb-23


Technical View of Abeona Therapeutics Inc
RSI

41.50

Neutral
MACD

-0.511

Bullish
ADX

16.55

Mild Bearish
Super Trend

5.39

Mild Bearish
Williams %R

-42.51

Neutral
CCI

20.43

Neutral


EMA 5

4.46

Strong Bearish
EMA 15

4.59

Neutral
EMA 50

5.59

Mild Bearish
EMA 100

5.71

Strong Bearish
SMA 100

6.07

Bearish
SMA 200

5.09

Strong Bearish
SMA 5 / 20

4.44 / 4.26

Bullish
SMA 15 / 50

4.32 / 6.30

Strong Bearish
SMA 50 / 200

6.30 / 5.09

Mild Bullish




Charts of Abeona Therapeutics Inc


Returns of Abeona Therapeutics Inc with Peers
Period / StockABEOBDSXGLSILFCR
1 Week4.76%-0.316%1.67%-6.53%
1 Mth-44.51%30.17%7.13%-10.11%
3 Mth-37.23%6.42%24.38%-28.33%
6mth5.01%10.14%30.53%-20.57%
1 Year48.65%30.17%19.08%17.87%
2 Year0.629%-7.35%47.00%-38.73%
5 Years-97.63%---40.53%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Abeona Therapeutics Inc with Peers
Ratio / StockABEOBDSXGLSILFCR
PE-392.99-2.94-18.88-2.33
P/B2686.57-143.8920.142.72
ROA-122.93-54.53-103.39-28.39
ROE-683.630-106.69-132.25
Debt To Equity0.0677.7601.36
Revenue3568.00 K
152.33 % 		44026.00 K
15.22 % 		0
% 		185786 K
0 %
Net Income-44718.00 K
2.85 % 		-63345.00 K
3.21 % 		-8935.58 K
14.19 % 		-46084.00 K
52.70 %


Technicals of Abeona Therapeutics Inc with Peers
Technical / StockABEOBDSXGLSILFCR-
ADX16.5522.8519.0014.04
CMF-0.3380.589-0.0110-0.0432
MFI75.4468.2857.1027.32
RSI41.5066.0548.9439.95
MACD Abv SignalTrueTrueTrueFalse
Price Above 50 MAFalseTrueFalseFalse-
Price Above 200 MAFalseTrueTrueFalse-


About : Abeona Therapeutics Inc

Address : 6555 Carnegie Avenue, Cleveland, OH, United States, 44103
Tel : 646 813 4701
URL : https://www.abeonatherapeutics.com
Code : ABEO, ISIN : US00289Y1073, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 19_Sep_1980
Employee Count : 84

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is EB-101, an autologous, engineered cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company develops ABO-503 for the treatment of X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 for the treatment of autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. is headquartered in Cleveland, Ohio.


Note : All Data Generated at the End of Trading Hours (EOD Data)